Skip to main content

Table 5 Validated parameters of the QSAR model

From: Theoretical activity prediction, structure-based design, molecular docking and pharmacokinetic studies of some maleimides against Leishmania donovani for the treatment of leishmaniasis

Validation parameters

Model

Threshold

Remarks

Training set

   

Friedman LOF

0.151244

R-squared (R2)

0.801298

 ≥ 0.6

Passed

Adjusted R-squared (\(R_{{{\text{adj}}}}^{2}\))

0.748311

 ≥ 0.5

Passed

Cross-validated R-squared (\(Q_{{{\text{cv}}}}^{2}\))

0.710284

 ≥ 0.5

Passed

R2 − \(Q_{{{\text{cv}}}}^{2}\)

0.091014

 ≤ 0.3

Passed

Significant regression

Yes

Significance-of-regression F-value

15.122516

Critical SOR F-value (95%)

3.103976

Replicate points

1

Computed experimental error

0.21286

Lack-of-fit points

14

Min expt. error for nonsignificant LOF (95%)

0.000000

Test set

 

R-squared (\(R_{{{\text{test}}}}^{2}\)) i.e.\(r^{2}\)

0.892

 ≥ 0.6

Passed

Number of test set compounds (Ntest set)

8

 ≥ 5

Passed

\(\left| {r_{o}^{2} - r_{o}^{{{^{\prime}}2}} } \right|\)

0.00599

˂ 0.3

Passed

\(\left| {r^{2} - \frac{{r_{o}^{{{^{\prime}}2}} }}{{r^{2} }}} \right|\)

0.00093

˂ 0.1

Passed

kʹ

1.03956

0.85 ≤ kʹ ≤ 1.15

Passed